Surveillance for Salmonella in horses in
However, the counties from which they were reported differed from S. Typhimurium with Cornwall, Hampshire, Lincolnshire and North Yorkshire being responsible for only 14% of reports of mST in horses. The majority of mST reports in horses (30%) were single incidents reported from 21 different counties.
Antimicrobial resistance in Salmonella isolates from horses
Antimicrobial use in cases is contentious but reports of antimicrobials typically used alone or in combination for the treatment of salmonellosis in horses include ceftiofur, enrofloxacin, and gentamicin. Multidrug-resistant Salmonella isolates from horses have been frequently reported, particularly among those serovars that are most commonly associated with clinical disease. Antimicrobial-resistant Salmonella isolates limit treatment options and increase the risk for therapeutic failure in veterinary clinical settings (Cummings et al., 2016) . Surveillance programmes on antimicrobial resistance in Salmonella from healthy horses are very limited, and the majority of available information relates to samples submitted for diagnostic purposes from diseased animals, and therefore likely to be skewed (Weese, 2015) . In GB, Salmonella isolates received for serological identification at APHA are tested for their in vitro sensitivity to a panel of 16 antimicrobials. The choice of antimicrobials, which is reviewed periodically, comprises a core set which has been used in veterinary practice for many years and also some more recently licensed antimicrobials and some which are not authorised for use in animals in the UK, but which are used in human medicine. All tests are carried out using British Society for Antimicrobial Chemotherapy (BSAC)-recommended disc concentrations. Since 1996, only the first Salmonella isolate from each incident has usually been tested, so that the data are not skewed by testing multiple isolates from the same incident. Of the equine Salmonella samples that were tested for antimicrobial susceptibility between 2008 and 2017, the percentage of samples that were fully susceptible to all the antimicrobials tested against ranged from 55% (in 2013) to 77% (in 2017). The most commonly reported resistance pattern between 2008 and 2017 was tetracycline, ampicillin, streptomycin and sulphonamide compounds (T, AM, S, Su) which was found in 13% of samples that were tested for antimicrobial susceptibility. In 2016, an extended spectrum beta-lactamase (ESBL)-producing Salmonella Oslo was responsible for an outbreak in an equine hospital. The isolation of ESBL-producing Salmonella from livestock in the UK is a rare occurrence, and incursions are followed up due to the risk they can pose to animal and human health. An advisory visit by APHA was carried out to the premises and ESBL-producing Salmonella and Escherichia coli were isolated from faecal and environmental samples. Although some of the human contacts reported diarrhoeal illness at the time of the outbreak, laboratory investigation of human cases was not performed. The veterinarians at the premises reported that a fourth generation cephalosporin drug was administered to horses undergoing surgery and that ESBL-producing E. coli had previously been isolated from wound infections in some horses.
Although the Salmonella Oslo isolated from the outbreak's index case (a horse admitted to the hospital with diarrhoeal illness) was sensitive to all drugs tested, isolates from subsequent cases were ESBL-producers. This suggested that the sensitive Salmonella Oslo, introduced to the premises by an infected horse, had acquired an ESBL plasmid at the equine hospital from E. coli or other Enterobacteriaceae. ESBL-producing Enterobacteriaceae have frequently been reported as a cause of severe infection in horses, and some studies have reported that as many as 10.7% of horses admitted to equine hospitals are carriers (Walther et al 2018) . Transfer and/or selection of resistance genes is likely to occur in vivo in the horse gut microbiome, and Salmonella strains could become resistant through horizontal gene transfer (Sadikalay et al., 2018) .
